The Role of Bcl-xL Protein in Viral Infections

被引:11
作者
Wyzewski, Zbigniew [1 ]
switlik, Weronika [2 ]
Mielcarska, Matylda Barbara [3 ]
Gregorczyk-Zboroch, Karolina Paulina [3 ]
机构
[1] Cardinal Stefan Wyszynski Univ Warsaw, Inst Biol Sci, PL-01815 Warsaw, Poland
[2] Warsaw Univ Life Sci SGGW, Inst Biol, Dept Biochem & Microbiol, PL-02787 Warsaw, Poland
[3] Warsaw Univ Life Sci, Inst Vet Med, PL-02787 Warsaw, Poland
关键词
Bcl-xL; HBV; HCV; HIV; IAV; EBV; HTLV-1; MRBV; SBV; CoV; EPSTEIN-BARR-VIRUS; HEPATITIS-C VIRUS; MARABA VIRUS; CELL-DEATH; NEUROCOGNITIVE DISORDER; INDEPENDENT PATHWAYS; PROMOTES SURVIVAL; OXIDATIVE STRESS; IN-VITRO; APOPTOSIS;
D O I
10.3390/ijms22041956
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bcl-xL represents a family of proteins responsible for the regulation of the intrinsic apoptosis pathway. Due to its anti-apoptotic activity, Bcl-xL co-determines the viability of various virally infected cells. Their survival may determine the effectiveness of viral replication and spread, dynamics of systemic infection, and viral pathogenesis. In this paper, we have reviewed the role of Bcl-xL in the context of host infection by eight different RNA and DNA viruses: hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), influenza A virus (IAV), Epstein-Barr virus (EBV), human T-lymphotropic virus type-1 (HTLV-1), Maraba virus (MRBV), Schmallenberg virus (SBV) and coronavirus (CoV). We have described an influence of viral infection on the intracellular level of Bcl-xL and discussed the impact of Bcl-xL-dependent cell survival control on infection-accompanying pathogenic events such as tissue damage or oncogenesis. We have also presented anti-viral treatment strategies based on the pharmacological regulation of Bcl-xL expression or activity.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 50 条
  • [31] Bcl-xL inhibits tBid and Bax via distinct mechanisms
    Murad, Fabronia
    Garcia-Saez, Ana J.
    FARADAY DISCUSSIONS, 2021, 232 (00) : 86 - 102
  • [32] Cytotoxicity of red fluorescent protein DsRed is associated with the suppression of Bcl-xL translation
    Zhou, Jun
    Lin, Jian
    Zhou, Cuihong
    Deng, Xiaoyan
    Xia, Bin
    FEBS LETTERS, 2011, 585 (05): : 821 - 827
  • [33] Modulation of synaptic transmission by the BCL-2 family protein BCL-xL
    Jonas, EA
    Hoit, D
    Hickman, JA
    Brandt, TA
    Polster, BM
    Fannjiang, Y
    McCarthy, E
    Montanez, MK
    Hardwick, JM
    Kaczmarek, LK
    JOURNAL OF NEUROSCIENCE, 2003, 23 (23) : 8423 - 8431
  • [34] Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma
    S Yoshimine
    E Kikuchi
    T Kosaka
    S Mikami
    A Miyajima
    Y Okada
    M Oya
    British Journal of Cancer, 2013, 108 : 2312 - 2320
  • [35] Profiling Anti-Apoptotic BCL-xL Protein Expression in Glioblastoma Tumorspheres
    Fanfone, Deborah
    Idbaih, Ahmed
    Mammi, Jade
    Gabut, Mathieu
    Ichim, Gabriel
    CANCERS, 2020, 12 (10) : 1 - 14
  • [36] Targeting Bcl-xL enhances the cytotoxicity of chemotherapeutics
    Wang, Shulin
    CANCER BIOLOGY & THERAPY, 2008, 7 (01) : 61 - 62
  • [37] Apoptosis induces Bcl-XS and cleaved Bcl-XL in chronic lymphocytic leukaemia
    Willimott, Shaun
    Merriam, Thomas
    Wagner, Simon D.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 405 (03) : 480 - 485
  • [38] Bcl-xL overexpression in human hepatocellular carcinoma
    Watanabe, J
    Kushihata, F
    Honda, K
    Mominoki, K
    Matsuda, S
    Kobayashi, N
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 21 (03) : 515 - 519
  • [39] Continuous expression of Bcl-xL protein during megakaryopoiesis is post-translationally regulated by thrombopoietin-mediated Akt activation, which prevents the cleavage of Bcl-xL
    Kozuma, Y.
    Kojima, H.
    Yuki, S.
    Suzuki, H.
    Nagasawa, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (06) : 1274 - 1282
  • [40] Role of Bcl-xL in paracetamol-induced tubular epithelial cell death
    Lorz, C
    Justo, P
    Sanz, AB
    Egido, J
    Ortíz, A
    KIDNEY INTERNATIONAL, 2005, 67 (02) : 592 - 601